These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19678422)

  • 1. Abstracts of the XVIII International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications, June 9-13, 2009, Fort Myers, Florida, USA.
    Antivir Ther; 2009; 14(4):A1-197. PubMed ID: 19678422
    [No Abstract]   [Full Text] [Related]  

  • 2. Abstracts of the XVII International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications, June 10-14, 2008, Sitges, Spain.
    Antivir Ther; 2008; 13(4):P1-4, A3-178. PubMed ID: 18785335
    [No Abstract]   [Full Text] [Related]  

  • 3. Abstracts presented at the XII International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications. 10-14 June 2003, Los Cabos, Mexico.
    Antivir Ther; 2003 Jun; 8(3):S1-170. PubMed ID: 14703650
    [No Abstract]   [Full Text] [Related]  

  • 4. Abstracts of the XI International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications. 2-5 July 2002, Seville, Spain.
    Antivir Ther; 2002; 7 Suppl 1():S1-215. PubMed ID: 12222537
    [No Abstract]   [Full Text] [Related]  

  • 5. Abstracts of the XIV International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications. 7-11 June 2005, Quebec City, Canada.
    Antivir Ther; 2005; 10 Suppl 1():P3-4, S3-181. PubMed ID: 16334453
    [No Abstract]   [Full Text] [Related]  

  • 6. Abstracts from the XVI International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications. June 12-16, 2007. Barbados, West Indies.
    Antivir Ther; 2007; 12(5):P3-4, S3-174. PubMed ID: 17899670
    [No Abstract]   [Full Text] [Related]  

  • 7. Basic principles and clinical implications. Abstracts from the XIV International HIV Drug Resistance Workshop. June 7-11, 2005. Québec City, Québec, Canada.
    Antivir Ther; 2005; 10(4):S3-181. PubMed ID: 16163812
    [No Abstract]   [Full Text] [Related]  

  • 8. Abstracts of the 3rd International Workshop on HIV Drug Resistance and Treatment Strategies. 23-26 June 1999, San Diego, California, USA.
    Antivir Ther; 1999; 4 Suppl 1():1-129. PubMed ID: 12387260
    [No Abstract]   [Full Text] [Related]  

  • 9. 4th International Workshop on HIV Drug Resistance and Treatment Strategies. Sitges, Spain, 12-16 June 2000. Abstracts.
    Antivir Ther; 2000; 5 Suppl 3():1-161. PubMed ID: 10963027
    [No Abstract]   [Full Text] [Related]  

  • 10. Are resistance puzzlers caught in a data quagmire? XIV International HIV Drug Resistance Workshop. June 7-11, 2005, Quebec, Canada.
    Mascolini M
    IAPAC Mon; 2005 Sep; 11(9):256-64, 267-75. PubMed ID: 16363042
    [No Abstract]   [Full Text] [Related]  

  • 11. Report from the XV International HIV Drug Resistance Workshop.
    Kuritzkes DR
    AIDS Clin Care; 2006 Sep; 18(9):83-4. PubMed ID: 16995272
    [No Abstract]   [Full Text] [Related]  

  • 12. Report from the XVII International HIV Drug Resistance Workshop.
    Kuritzkes DR
    AIDS Clin Care; 2008 Aug; 20(8):61-2. PubMed ID: 18814368
    [No Abstract]   [Full Text] [Related]  

  • 13. 5th International Workshop on HIV Drug Resistance & Treatment Strategies. 4-8 June 2001, Scottsdale, Arizona. Abstracts.
    Antivir Ther; 2001; 6 Suppl 1():1-141. PubMed ID: 11439941
    [No Abstract]   [Full Text] [Related]  

  • 14. Slow accumulation of HIV resistance mutations: implications for resource-limited settings?
    Stevens WS
    J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045
    [No Abstract]   [Full Text] [Related]  

  • 15. Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.
    Hicks CB
    AIDS Clin Care; 2008 Aug; 20(8):64. PubMed ID: 18814369
    [No Abstract]   [Full Text] [Related]  

  • 16. Report from the XVIII International HIV Drug Resistance Workshop.
    Kuritzkes DR
    J Watch AIDS Clin Care; 2009 Oct; 21(10):85-6. PubMed ID: 20458804
    [No Abstract]   [Full Text] [Related]  

  • 17. Why HIV drug resistance matters: an overview.
    Learned J
    Posit Aware; 2005; 16(5):26-30. PubMed ID: 16220604
    [No Abstract]   [Full Text] [Related]  

  • 18. Resistance seen in newly diagnosed patients.
    AIDS Patient Care STDS; 2003 Dec; 17(12):665. PubMed ID: 14746660
    [No Abstract]   [Full Text] [Related]  

  • 19. Update of the drug resistance mutations in HIV-1: 2004.
    Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
    Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiretroviral rounds. Resistance: how do you know if you don't know?
    Campbell TB; Katzenstein D
    AIDS Clin Care; 2005 Mar; 17(3):26-7. PubMed ID: 15828117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.